Position in DNLI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$73,574,732
+$21,884,975 QoQ
Shares Held
2,860,604
+6.3% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 6%
None 4%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. DNLI ranks #22 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,574,732 | 2,860,604 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $51,689,757 | 2,692,175 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $39,199,740 | 2,374,303 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $34,226,745 | 2,357,214 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $33,756,860 | 2,412,928 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,561,134 | 2,100,856 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $37,805,631 | 1,855,036 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $45,426,543 | 1,559,442 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $32,913,699 | 1,417,472 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $27,352,131 | 1,332,950 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $24,027,214 | 1,119,628 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $20,077,814 | 973,234 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $22,274,174 | 754,801 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $14,453,566 | 627,325 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,525,151 | 558,258 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $18,715,957 | 609,839 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $26,242,082 | 891,678 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,252,466 | 878,224 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $34,439,986 | 772,197 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $32,022,380 | 634,735 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,520,297 | 325,348 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $24,050,634 | 421,202 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $37,924,852 | 452,780 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $19,173,313 | 535,119 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $13,315,853 | 550,697 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $9,873,171 | 563,859 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||